Journey Medical GAAP EPS of -$0.09, revenue of $17.6M
Source: SeekingAlpha
2025-11-12 17:29:04 ET
More on Journey Medical
- Journey Medical: EMROSI's Ramp Puts Profitability On The Horizon
- Seeking Alpha’s Quant Rating on Journey Medical
- Historical earnings data for Journey Medical
- Financial information for Journey Medical
Read the full article on Seeking Alpha
For further details see:
Journey Medical GAAP EPS of -$0.09, revenue of $17.6M
Journey Medical Corporation
NASDAQ: DERM
DERM Trading
-5.64% G/L:
$7.36 Last:
72,980 Volume:
$8.04 Open:
DERM Latest News
December 10, 2025 08:30:00 am
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi(TM) (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
November 12, 2025 04:01:00 pm
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
DERM Stock Data
$266,218,987
14,090,816
2.7%
16
N/A
Pharmaceuticals
Healthcare
US
Scottsdale
